David Harding

3.9k total citations
91 papers, 2.9k citations indexed

About

David Harding is a scholar working on Molecular Biology, Spectroscopy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Harding has authored 91 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 21 papers in Spectroscopy and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Harding's work include Chemical Synthesis and Analysis (23 papers), Analytical Chemistry and Chromatography (20 papers) and Neonatal Respiratory Health Research (15 papers). David Harding is often cited by papers focused on Chemical Synthesis and Analysis (23 papers), Analytical Chemistry and Chromatography (20 papers) and Neonatal Respiratory Health Research (15 papers). David Harding collaborates with scholars based in New Zealand, United Kingdom and United States. David Harding's co-authors include Simon C. Burton, William S. Hancock, C.A. Bishop, Brian Burchell, Sylvie Fournel‐Gigleux, Ross L. Prestidge, Milton T.W. Hearn, Michael R. Jackson, Steve E. Humphries and Michael R. Jackson and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

David Harding

89 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Harding New Zealand 30 1.2k 592 550 382 301 91 2.9k
Jan den Hartigh Netherlands 36 772 0.7× 103 0.2× 559 1.0× 354 0.9× 653 2.2× 99 3.8k
Janusz Marcinkiewicz Poland 35 988 0.8× 240 0.4× 193 0.4× 166 0.4× 166 0.6× 136 3.5k
Günther Hochhaus United States 35 789 0.7× 148 0.3× 286 0.5× 1.8k 4.8× 236 0.8× 184 4.3k
Yan Chen China 31 1.1k 0.9× 408 0.7× 140 0.3× 199 0.5× 592 2.0× 185 3.8k
Andrew Fitton United Kingdom 34 758 0.7× 107 0.2× 300 0.5× 224 0.6× 518 1.7× 53 4.1k
Dominique Porquet France 22 932 0.8× 116 0.2× 699 1.3× 158 0.4× 217 0.7× 87 2.5k
Kunihiko Itoh Japan 32 1.5k 1.3× 65 0.1× 333 0.6× 157 0.4× 208 0.7× 205 4.3k
Steven W. Graves United States 28 894 0.8× 186 0.3× 536 1.0× 494 1.3× 110 0.4× 98 2.6k
James E. Frampton New Zealand 40 1.3k 1.1× 69 0.1× 228 0.4× 390 1.0× 532 1.8× 166 5.0k
Mamoru Satoh Japan 45 2.4k 2.0× 238 0.4× 96 0.2× 315 0.8× 557 1.9× 196 5.3k

Countries citing papers authored by David Harding

Since Specialization
Citations

This map shows the geographic impact of David Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Harding more than expected).

Fields of papers citing papers by David Harding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Harding. The network helps show where David Harding may publish in the future.

Co-authorship network of co-authors of David Harding

This figure shows the co-authorship network connecting the top 25 collaborators of David Harding. A scholar is included among the top collaborators of David Harding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Harding. David Harding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luyt, Karen, et al.. (2020). Treatment for Post-hemorrhagic Ventricular Dilatation: A Multiple-Treatment Meta-Analysis. Frontiers in Pediatrics. 8. 238–238. 12 indexed citations
2.
Talaat, Wael, Sausan Al Kawas, Nadia G. Kandile, et al.. (2020). <p>Nanoscale Thermosensitive Hydrogel Scaffolds Promote the Chondrogenic Differentiation of Dental Pulp Stem and Progenitor Cells: A Minimally Invasive Approach for Cartilage Regeneration</p>. International Journal of Nanomedicine. Volume 15. 7775–7789. 32 indexed citations
3.
Rajatileka, Shavanthi, David Odd, Matthew T. Robinson, et al.. (2017). Variants of the EAAT2 Glutamate Transporter Gene Promoter Are Associated with Cerebral Palsy in Preterm Infants. Molecular Neurobiology. 55(3). 2013–2024. 16 indexed citations
4.
Niimi, Kyoko, David Harding, Ann R. Holmes, et al.. (2012). Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a d‐octapeptide derivative inhibitor. Molecular Microbiology. 85(4). 747–767. 38 indexed citations
5.
Stephenson, Rachel J., Paul G. Plieger, & David Harding. (2011). Improved Fmoc Synthesis of Bradykinin. Protein and Peptide Letters. 18(9). 952–955. 2 indexed citations
6.
Chakkarapani, Ela, et al.. (2009). Therapeutic hypothermia: surgical infant with neonatal encephalopathy. Acta Paediatrica. 98(11). 1844–1846. 5 indexed citations
7.
Al‐Ghobashy, Medhat A., et al.. (2009). Probing the interaction between recombinant human myelin basic protein and caseins using surface plasmon resonance and diffusing wave spectroscopy. Journal of Molecular Recognition. 23(1). 84–92. 14 indexed citations
8.
Hastings, Rob, David Harding, Alan Donaldson, et al.. (2009). Mardini–Nyhan association (lung agenesis, congenital heart, and thumb anomalies): Three new cases and possible recurrence in a sib—Is there a distinct recessive syndrome?. American Journal of Medical Genetics Part A. 149A(12). 2838–2842. 11 indexed citations
9.
Harding, David, et al.. (2006). Cognitive outcome and cyclo-oxygenase-2 gene (−765 G/C) variation in the preterm infant. Archives of Disease in Childhood Fetal & Neonatal. 92(2). F108–F112. 21 indexed citations
10.
Harding, David, Sukhbir Dhamrait, Steve E. Humphries, et al.. (2005). Does angiotensin-1 converting enzyme genotype influence motor or cognitive development after pre-term birth?. Journal of Neuroinflammation. 2(1). 6–6. 5 indexed citations
11.
Harding, David, David Brull, Steve E. Humphries, et al.. (2005). Variation in the Interleukin-6 Gene Is Associated with Impaired Cognitive Development in Children Born Prematurely: A Preliminary Study. Pediatric Research. 58(1). 117–120. 32 indexed citations
12.
Harding, David, Sukhbir Dhamrait, Neil Marlow, et al.. (2003). Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants. The Journal of Pediatrics. 143(6). 746–749. 29 indexed citations
13.
Harding, David, S Dhamrait, Hugh Montgomery, et al.. (2002). Does IL6-174 genotype predict the development of septicaemia in preterm infants?. UCL Discovery (University College London). 1 indexed citations
14.
Harding, David, David Brull, Vassilios S. Vassiliou, et al.. (2002). Severity of Meningococcal Disease in Children and the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism. American Journal of Respiratory and Critical Care Medicine. 165(8). 1103–1106. 55 indexed citations
15.
Burton, Simon C. & David Harding. (2001). Salt-independent adsorption chromatography: new broad-spectrum affinity methods for protein capture. Journal of Biochemical and Biophysical Methods. 49(1-3). 275–287. 52 indexed citations
16.
Goff, Joshua, David Harding, Rajesh Shah, & Marc Singer. (1998). A New Way to Reach Small Businesses. The McKinsey Quarterly. 1(3). 172. 3 indexed citations
17.
Harding, David, Carl A Kuschel, & N Evans. (1998). Should preterm infants born after 29 weeks’ gestation be screened for intraventricular haemorrhage?. Journal of Paediatrics and Child Health. 34(1). 57–59. 13 indexed citations
18.
Harding, David, et al.. (1989). Formic acid as a milder alternative to trifluoroacetic acid and phosphoric acid in two-dimensional peptide mapping. Journal of Chromatography A. 469. 231–239. 7 indexed citations
19.
Harding, David, et al.. (1989). Phenol UDP-glucuronosyltransferase deficiency in Gunn rats: mRNA levels are considerably reduced. Biochemical Pharmacology. 38(6). 1013–1017. 7 indexed citations
20.
Bishop, C.A., et al.. (1979). Application of Reversed Phase High Performance Liquid Chromatography in Solid Phase Peptide Synthesis. Journal of Liquid Chromatography. 2(1). 1–21. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan den Hartigh Breakdown of academic impact, for papers by Janusz Marcinkiewicz Breakdown of academic impact, for papers by Günther Hochhaus Breakdown of academic impact, for papers by Yan Chen Breakdown of academic impact, for papers by Andrew Fitton Breakdown of academic impact, for papers by Dominique Porquet Breakdown of academic impact, for papers by Kunihiko Itoh Breakdown of academic impact, for papers by Steven W. Graves Breakdown of academic impact, for papers by James E. Frampton Breakdown of academic impact, for papers by Mamoru Satoh
Rankless by CCL
2026